Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
and was approved by the FDA on February 25
and increases their cytotoxicity 3
Chemical Name: N-(2-{[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino}-1H-1
leading to an increase in the rate of protein synthesis
Formula: C66H103N13O13S
Methsuximide Catalog No.:M22869-C and was approved by theMethsuximide (or methsuximide, methosuximide, Celontin) is a succinimide anticonvulsant medication that is pharmacologically converted to its active metabolite N desmethylmethosuximide, a channel blocker that targets low threshold calcium currents. Methsuximide effectively suppressed the initial clonic seizures induced by Metrazol in rats and mice. Methsuximide was capable of protecting mice from tonic extensor seizures to supramaximal electroshock .
US$ 119.00
US$ 128.00
US$ 118.50
US$ 183.00
US$ 108.00